|
Miltenyi Biotec
psc derived cardiomyocyte isolation kit ![]() Psc Derived Cardiomyocyte Isolation Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+cardiomyocytes/PSC-Derived+Cardiomyocyte+Isolation+Kit%2C+human/bio_rxiv__64898__2026__10__01__755665-39-21-26 Average 94 stars, based on 1 article reviews
psc derived cardiomyocyte isolation kit - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Celprogen Inc
human cardiomyocyte cells ![]() Human Cardiomyocyte Cells, supplied by Celprogen Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+cardiomyocytes/Human+Cardiomyocyte+Cell+Culture/pmc13409955-42-0-6 Average 93 stars, based on 1 article reviews
human cardiomyocyte cells - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
PromoCell
hcm c 12810 ![]() Hcm C 12810, supplied by PromoCell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+cardiomyocytes/Human+Cardiac+Myocytes/pm42816593-312-0-8 Average 95 stars, based on 1 article reviews
hcm c 12810 - by Bioz Stars,
2026-11
95/100 stars
|
Buy from Supplier |
|
Axol Bioscience
human induced pluripotent stem cell derived ventricular cardiomyocytes ![]() Human Induced Pluripotent Stem Cell Derived Ventricular Cardiomyocytes, supplied by Axol Bioscience, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+cardiomyocytes/Human+iPSC-Derived+Ventricular+Cardiomyocytes/10__3390_slash_life16101627-89-5-16 Average 94 stars, based on 1 article reviews
human induced pluripotent stem cell derived ventricular cardiomyocytes - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
ATCC
human cardiomyocyte ac16 cell line ![]() Human Cardiomyocyte Ac16 Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+cardiomyocytes/AC16/pm42600511-312-1-6 Average 97 stars, based on 1 article reviews
human cardiomyocyte ac16 cell line - by Bioz Stars,
2026-11
97/100 stars
|
Buy from Supplier |
|
PromoCell
c 12810 ![]() C 12810, supplied by PromoCell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+cardiomyocytes/Human+Cardiac+Myocytes/10__1038_slash_s41419___026___09229___4-85-22-21 Average 95 stars, based on 1 article reviews
c 12810 - by Bioz Stars,
2026-11
95/100 stars
|
Buy from Supplier |
|
ATCC
human ventricular cardiomyocyte line ac16 ![]() Human Ventricular Cardiomyocyte Line Ac16, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+cardiomyocytes/AC16/pm41944987-64-1-9 Average 97 stars, based on 1 article reviews
human ventricular cardiomyocyte line ac16 - by Bioz Stars,
2026-11
97/100 stars
|
Buy from Supplier |
|
Celprogen Inc
human cardiomyocyte serum free media ![]() Human Cardiomyocyte Serum Free Media, supplied by Celprogen Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+cardiomyocytes/Human+Cardiomyocyte+Serum+Free+Media/pmc13409955-37-6-10 Average 94 stars, based on 1 article reviews
human cardiomyocyte serum free media - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Celprogen Inc
human cardiomyocyte complete media with serum ![]() Human Cardiomyocyte Complete Media With Serum, supplied by Celprogen Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+cardiomyocytes/Human+Cardiomyocyte+Complete+Media+with+Serum/custom%40m36044-15s%4042505916 Average 93 stars, based on 1 article reviews
human cardiomyocyte complete media with serum - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Celprogen Inc
e36044 15 t25 ![]() E36044 15 T25, supplied by Celprogen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+cardiomyocytes/Human+Cardiomyocyte+Primary+Cell+Culture+Extracellular+Expansion+Matrix/pmc13409955-46-1-2 Average 90 stars, based on 1 article reviews
e36044 15 t25 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
Journal: bioRxiv
Article Title: Lead Exposure During Differentiation Perturbs Electrophysiological Function in iPSC-Derived Cardiomyocytes in a Cell Line-Dependent Manner
doi: 10.64898/2026.10.01.755665
Figure Lengend Snippet: Differentiation protocol and subsequent purification, with Pb exposure on the first 8 days of differentiation, purification between days 10-20, and optical mapping performed for purified cardiomyocytes 7-10 days after purification.
Article Snippet: Cardiomyocytes derived above (both control and Pb exposed) were purified once beating was visualized throughout each well (days 10-20), using the
Techniques: Purification
Journal: bioRxiv
Article Title: Lead Exposure During Differentiation Perturbs Electrophysiological Function in iPSC-Derived Cardiomyocytes in a Cell Line-Dependent Manner
doi: 10.64898/2026.10.01.755665
Figure Lengend Snippet: For ECC genes ATP2A2 , CACNA1C, RYR2 , and SLC8A1 and K channel subunits HERG1A and B, no significant changes were observed for purified cardiomyocytes for either female or male cells treated with 0.5 and 5 µM Pb during the first 8 days of differentiation (n = 3 per cell line per treatment; one-way ANOVA p-values for each comparison labeled on the graphs).
Article Snippet: Cardiomyocytes derived above (both control and Pb exposed) were purified once beating was visualized throughout each well (days 10-20), using the
Techniques: Purification, Comparison, Labeling, Gene Expression
Journal: Journal of Cardiovascular Development and Disease
Article Title: The Mitigating Effect of Remifentanil Against Sevoflurane-Induced Cardiotoxicity in Human Cardiomyocytes via TRPA1 Channels
doi: 10.3390/jcdd13070339
Figure Lengend Snippet: Anaesthesia device and airtight chamber system used during 5.1% sevoflurane exposure of cardiomyocyte cells.
Article Snippet:
Techniques:
Journal: Journal of Cardiovascular Development and Disease
Article Title: The Mitigating Effect of Remifentanil Against Sevoflurane-Induced Cardiotoxicity in Human Cardiomyocytes via TRPA1 Channels
doi: 10.3390/jcdd13070339
Figure Lengend Snippet: ( A , B ) The effect of sevoflurane (SEV, 5.1%, 6 h) and remifentanil (REM, 2.5 µM, 30 min) on cytosolic calcium levels in cardiomyocyte cells. Cells were stimulated by cinnamaldehyde (CIN, 0.1 mM, on the 20th cycle) but were inhibited by AP18 (0.1 mM for 30 min) (mean ± SD, n = 3). a p ˂ 0.001 and b p ˂ 0.05 vs. control, c p ˂ 0.001 vs. SEV, d p ˂ 0.001 vs. REM, and e p ˂ 0.05 vs. SEV + REM group.
Article Snippet:
Techniques: Control
Journal: Journal of Cardiovascular Development and Disease
Article Title: The Mitigating Effect of Remifentanil Against Sevoflurane-Induced Cardiotoxicity in Human Cardiomyocytes via TRPA1 Channels
doi: 10.3390/jcdd13070339
Figure Lengend Snippet: The effect of sevoflurane (SEV, 5.1%, 6 h) and remifentanil (REM, 2.5 µM, 30 min) on apoptosis levels in cardiomyocyte cells. Cells were stimulated by cinnamaldehyde (CIN, 0.1 mM for 10 min) but were inhibited by AP18 (0.1 mM for 30 min) (mean ± SD, n = 10). a p ˂ 0.001 vs. control, b p ˂ 0.001 vs. SEV, c p ˂ 0.005 and d p ˂ 0.001 vs. REM, and e p ˂ 0.05 vs. SEV + REM.
Article Snippet:
Techniques: Control
Journal: Journal of Cardiovascular Development and Disease
Article Title: The Mitigating Effect of Remifentanil Against Sevoflurane-Induced Cardiotoxicity in Human Cardiomyocytes via TRPA1 Channels
doi: 10.3390/jcdd13070339
Figure Lengend Snippet: The effect of sevoflurane (SEV, 5.1%, 6 h) and remifentanil (REM, 2.5 µM, 30 min) on reactive oxygen and mitochondrial depolarisation levels in cardiomyocyte cells. Cells were stimulated by cinnamaldehyde (CIN, 0.1 mM for 10 min) but were inhibited by AP18 (0.1 mM for 30 min) (mean ± SD, n = 10). a p ˂ 0.001 and b p ˂ 0.05 vs. control, c p ˂ 0.001 vs. SEV, e p ˂ 0.001 and f p ˂ 0.05 vs. REM, and g p ˂ 0.001 vs. SEV + REM.
Article Snippet:
Techniques: Control
Journal: Journal of Cardiovascular Development and Disease
Article Title: The Mitigating Effect of Remifentanil Against Sevoflurane-Induced Cardiotoxicity in Human Cardiomyocytes via TRPA1 Channels
doi: 10.3390/jcdd13070339
Figure Lengend Snippet: The effect of sevoflurane (SEV, 5.1%, 6 h) and remifentanil (REM, 2.5 µM, 30 min) on caspase-3 and caspase-9 levels in the cardiomyocyte cells. Cells were stimulated by cinnamaldehyde (CIN, 0.1 mM for 10 min) but were inhibited by AP18 (0.1 mM for 30 min) (mean ± SD, n = 10). a p ˂ 0.001 vs. control, b p ˂ 0.001 vs. SEV, c p ˂ 0.001 vs. REM, and d p ˂ 0.001 vs. SEV + REM.
Article Snippet:
Techniques: Control
Journal: Journal of Cardiovascular Development and Disease
Article Title: The Mitigating Effect of Remifentanil Against Sevoflurane-Induced Cardiotoxicity in Human Cardiomyocytes via TRPA1 Channels
doi: 10.3390/jcdd13070339
Figure Lengend Snippet: Anaesthesia device and airtight chamber system used during 5.1% sevoflurane exposure of cardiomyocyte cells.
Article Snippet: Human Cardiomyocyte Complete Media with Serum,
Techniques:
Journal: Journal of Cardiovascular Development and Disease
Article Title: The Mitigating Effect of Remifentanil Against Sevoflurane-Induced Cardiotoxicity in Human Cardiomyocytes via TRPA1 Channels
doi: 10.3390/jcdd13070339
Figure Lengend Snippet: ( A , B ) The effect of sevoflurane (SEV, 5.1%, 6 h) and remifentanil (REM, 2.5 µM, 30 min) on cytosolic calcium levels in cardiomyocyte cells. Cells were stimulated by cinnamaldehyde (CIN, 0.1 mM, on the 20th cycle) but were inhibited by AP18 (0.1 mM for 30 min) (mean ± SD, n = 3). a p ˂ 0.001 and b p ˂ 0.05 vs. control, c p ˂ 0.001 vs. SEV, d p ˂ 0.001 vs. REM, and e p ˂ 0.05 vs. SEV + REM group.
Article Snippet: Human Cardiomyocyte Complete Media with Serum,
Techniques: Control
Journal: Journal of Cardiovascular Development and Disease
Article Title: The Mitigating Effect of Remifentanil Against Sevoflurane-Induced Cardiotoxicity in Human Cardiomyocytes via TRPA1 Channels
doi: 10.3390/jcdd13070339
Figure Lengend Snippet: The effect of sevoflurane (SEV, 5.1%, 6 h) and remifentanil (REM, 2.5 µM, 30 min) on apoptosis levels in cardiomyocyte cells. Cells were stimulated by cinnamaldehyde (CIN, 0.1 mM for 10 min) but were inhibited by AP18 (0.1 mM for 30 min) (mean ± SD, n = 10). a p ˂ 0.001 vs. control, b p ˂ 0.001 vs. SEV, c p ˂ 0.005 and d p ˂ 0.001 vs. REM, and e p ˂ 0.05 vs. SEV + REM.
Article Snippet: Human Cardiomyocyte Complete Media with Serum,
Techniques: Control
Journal: Journal of Cardiovascular Development and Disease
Article Title: The Mitigating Effect of Remifentanil Against Sevoflurane-Induced Cardiotoxicity in Human Cardiomyocytes via TRPA1 Channels
doi: 10.3390/jcdd13070339
Figure Lengend Snippet: The effect of sevoflurane (SEV, 5.1%, 6 h) and remifentanil (REM, 2.5 µM, 30 min) on reactive oxygen and mitochondrial depolarisation levels in cardiomyocyte cells. Cells were stimulated by cinnamaldehyde (CIN, 0.1 mM for 10 min) but were inhibited by AP18 (0.1 mM for 30 min) (mean ± SD, n = 10). a p ˂ 0.001 and b p ˂ 0.05 vs. control, c p ˂ 0.001 vs. SEV, e p ˂ 0.001 and f p ˂ 0.05 vs. REM, and g p ˂ 0.001 vs. SEV + REM.
Article Snippet: Human Cardiomyocyte Complete Media with Serum,
Techniques: Control
Journal: Journal of Cardiovascular Development and Disease
Article Title: The Mitigating Effect of Remifentanil Against Sevoflurane-Induced Cardiotoxicity in Human Cardiomyocytes via TRPA1 Channels
doi: 10.3390/jcdd13070339
Figure Lengend Snippet: The effect of sevoflurane (SEV, 5.1%, 6 h) and remifentanil (REM, 2.5 µM, 30 min) on caspase-3 and caspase-9 levels in the cardiomyocyte cells. Cells were stimulated by cinnamaldehyde (CIN, 0.1 mM for 10 min) but were inhibited by AP18 (0.1 mM for 30 min) (mean ± SD, n = 10). a p ˂ 0.001 vs. control, b p ˂ 0.001 vs. SEV, c p ˂ 0.001 vs. REM, and d p ˂ 0.001 vs. SEV + REM.
Article Snippet: Human Cardiomyocyte Complete Media with Serum,
Techniques: Control